Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.

FDA said on Thursday it would hold a meeting of outside experts ‌next month to review Moderna's experimental flu shot.

Moderna and rival Pfizer on Wednesday said their updated Covid-19 vaccines generated strong responses in testing against the highly mutated BA.2.86 subvariant of the coronavirus that has raised fears ...

Moderna Inc. MRNA will have its experimental mRNA-based flu vaccine reviewed by a Food and Drug Administration (FDA) advisory ...

The Therapeutic Goods Administration said Moderna would be able to be used as a booster regardless of what COVID-19 vaccine ...

Moderna on Friday posted fourth-quarter revenue that beat estimates, but lost more than expected for the period, as the biotech company continues to slash costs and demand for its Covid vaccine falls.

By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 ...

The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Messenger RNA technology, or mRNA, is widely ...